AI assistant
Sending…
EXPONENT INC — Director's Dealing 2017
Jun 2, 2017
31263_dirs_2017-06-02_aabb84b3-cc1e-46c8-9dc0-5f93984e3be4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXPONENT INC (EXPO)
CIK: 0000851520
Period of Report: 2017-05-31
Reporting Person: RICHARDSON KAREN A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-31 | Common Stock | M | 28 | — | Acquired | 6366 | Direct |
| 2017-05-31 | Common Stock | M | 2146 | — | Acquired | 8512 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-31 | Dividend Equivalent Rights | $ | A | 7 | Acquired | 2017-05-31 | Common Stock (7) | Direct |
| 2017-05-31 | Dividend Equivalent Rights | $ | M | 28 | Disposed | 2017-05-31 | Common Stock (28) | Direct |
| 2017-05-31 | Restricted Stock Units | $ | M | 2146 | Disposed | Common Stock (2146) | Direct | |
| 2017-06-01 | Restricted Stock Units | $ | A | 2021 | Acquired | Common Stock (2021) | Direct |
Footnotes
F1: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis.
F2: Not applicable.
F3: Reflects the conversion of shares of vested Restricted Stock Units granted on May 26, 2016 into shares of Common Stock on a 1:1 basis.
F4: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in Q1 2017.
F5: 1-for-1.
F6: Restricted stock units will cliff-vest on the day prior to the Company's next annual shareholder meeting.
More from EXPONENT INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 27